YOCHANRA Trademark

Trademark Overview

On Friday, June 3, 2022, a trademark application was filed for YOCHANRA with the United States Patent and Trademark Office. The USPTO has given the YOCHANRA trademark a serial number of 97442064. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by TransThera Sciences (Nanjing), Inc.. The YOCHANRA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; pharmaceutical preparations for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; drugs for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and di...
yochanra

General Information

Serial Number97442064
Word MarkYOCHANRA
Filing DateFriday, June 3, 2022
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7395011
Registration DateTuesday, May 28, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Description of MarkThe mark consists of a spherical design formed by three stacked offset curved lines on the bottom and three stacked offset curved dotted lines on the top with the word "YOCHANRA" to the right of the design.
Goods and ServicesMedicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; pharmaceutical preparations for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; drugs for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemico-pharmaceutical preparations for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemical preparations for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; biological preparations for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; bulk medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; biochemical medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemical preparations for pharmaceutical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; medicines in the nature of tablets for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; medicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders in the nature of capsule; injectable medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTransThera Sciences (Nanjing), Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNanjing, Jiangsu 210032
CN
Party NameTransThera Sciences (Nanjing), Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNanjing, Jiangsu 210032
CN
Party NameTransThera Sciences (Nanjing), Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNanjing, Jiangsu 210032
CN

Trademark Events

Event DateEvent Description
Tuesday, June 7, 2022NEW APPLICATION ENTERED
Monday, June 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 14, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 25, 2023ASSIGNED TO EXAMINER
Friday, March 3, 2023NON-FINAL ACTION WRITTEN
Friday, March 3, 2023NON-FINAL ACTION E-MAILED
Friday, March 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 28, 2023ASSIGNED TO LIE
Monday, August 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 12, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, September 12, 2023WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, November 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 10, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, February 6, 2024ASSIGNED TO PETITION STAFF
Wednesday, February 7, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, February 7, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, February 8, 2024NOTICE OF ALLOWANCE CANCELLED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

yochanra disorders diseases anemia metabolic associated cardiovascular treatment cancer inflammation skeletal